Long-term safety of tobramycin inhalation powder in patients with cystic fibrosis: phase IV (ETOILES) study.
about
Inhaled Antibiotic Therapy in Chronic Respiratory Diseases.Tobramycin inhalation powder for the treatment of pulmonary Pseudomonas aeruginosa infection in patients with cystic fibrosis: a review based on clinical evidence.Economic Evaluation of Tobramycin Inhalation Powder for the Treatment of Chronic Pulmonary Pseudomonas aeruginosa Infection in Patients with Cystic Fibrosis.
P2860
Long-term safety of tobramycin inhalation powder in patients with cystic fibrosis: phase IV (ETOILES) study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Long-term safety of tobramycin ...... sis: phase IV (ETOILES) study.
@en
type
label
Long-term safety of tobramycin ...... sis: phase IV (ETOILES) study.
@en
prefLabel
Long-term safety of tobramycin ...... sis: phase IV (ETOILES) study.
@en
P2093
P2860
P1476
Long-term safety of tobramycin ...... sis: phase IV (ETOILES) study.
@en
P2093
Andrea Viegas
Gerhild Angyalosi
Isabel Virella-Lowell
Laurie Debonnett
Urte Sommerwerck
Weihua Cao
P2860
P304
P356
10.1080/03007995.2016.1211516
P407
P577
2016-07-20T00:00:00Z